Top Startup and Tech Funding News – May 14, 2025

It’s Thursday, May 14, 2026, and we’re back with today’s top startup and tech funding news. Today’s rounds show investors leaning into platforms that sit close to real infrastructure: in vivo cell therapy, AI data center cooling, embedded banking payments, government permitting, healthcare AI measurement, and multimodal training data. The largest round went to CREATE Medicines, which raised $122 million to advance in vivo CAR-T programs, while fintech and AI workflow companies drew fresh capital to modernize banking, marketing, and public-sector operations.

The broader signal is clear: investors are still writing checks, but the money is moving toward companies that can prove operational leverage, not just promise it. From Iceotope’s liquid-cooling systems for high-density AI racks to Wirestock’s creator-powered data engine for foundation models, today’s deals reflect a market that prioritizes infrastructure, measurable ROI, and software capable of replacing legacy workflows in regulated sectors.

Tech Funding News

Funding Highlights

• CREATE Medicines raises $122M Series B for in vivo CAR-T expansion
• equipifi raises $34M Series B for embedded BNPL in banking
• Nectar Social raises $30M Series A for agentic marketing operations
• Iceotope raises $26M Series B for AI data center cooling
• Stitch raises $25M Series A for modern financial infrastructure
• GovWell raises $25M Series A for AI-powered government permitting
• Wirestock raises $23M Series A for multimodal AI training data
• Optura raises $17.5M Series A for healthcare AI ROI management
• Urologic Health raises $11M seed for non-invasive bladder monitoring
• Synthetic raises $10M seed for an autonomous startup in bookkeeping

Investor Activity

Today’s funding activity brought together biotech specialists, climate investors, fintech backers, enterprise software firms, and AI-focused venture funds. Newpath Partners, ARCH Venture Partners, and Hatteras backed the largest round in cell therapy, while Left Lane Capital, Andreessen Horowitz, Insight Partners, Khosla Ventures, Salesforce Ventures, and Menlo Ventures showed continued appetite for software infrastructure across banking, government, accounting, healthcare, and marketing. Across the board, capital flowed into companies trying to turn complex workflows into scalable platforms.

CREATE Medicines Raises $122M Series B for In Vivo CAR-T Expansion

General Medicine’s founding team has disrupted health care once. They’re trying again. Courtesy of General Medicine

CREATE Medicines, the biotech startup launched by the founders of PillPack alongside a former Amazon colleague, has raised $122 million in a Series B round co-led by returning investors Newpath Partners, ARCH Venture Partners, and Hatteras Venture Partners. Existing backers, including Alexandria Venture Investments, also participated in the financing.

The clinical-stage biotechnology startup is developing in vivo immune-programming therapies that aim to engineer immune cells directly within the body, rather than through the traditional ex vivo manufacturing process. The new Series B is earmarked to advance its repeat-dose-capable CD19-targeted in vivo CAR-T program into the clinic, expand its dual-CAR CD19 x BCMA program, and continue advancing its oncology portfolio.

Why this round matters: investors are still willing to write very large checks for differentiated cell-programming platforms, but only when there is a credible path from platform story to clinical execution. CREATE has already dosed more than 50 patients across its programs and recently moved MT-304 into a Phase 1/2 study, giving this raise more operating weight than pure concept-stage biotech stories.

Funding Details

• Startup: CREATE Medicines.
• Investors: Newpath Partners, ARCH Venture Partners, Hatteras Venture Partners, with participation from Alexandria Venture Investments and other current syndicate members.
• Amount Raised: $122M.
• Total Raised: Not disclosed.
• Funding Stage: Series B.
• Funding Date: May 14, 2026.

equipifi Raises $34M Series B for Embedded BNPL in Banking

equipifi sells the infrastructure that lets banks and credit unions offer flexible payments and buy now, pay later products directly inside their own digital banking experiences. The company’s pitch is simple: installment lending should sit inside the primary banking relationship, not be outsourced to third-party fintechs that own the consumer touchpoint.

Why this round matters: flexible payments are no longer a novelty category. equipifi says more than 82 million U.S. consumers now prefer these products, and adoption of bank-embedded flexible payments has more than tripled over the past year. That turns this into a bigger infrastructure bet on who controls the next layer of consumer payments: consumer-facing BNPL brands, or regulated institutions that want the economics and customer relationship back.

Funding Details

• Startup: equipifi.
• Investors: Left Lane Capital, with continued participation from Curql and PHX Ventures.
• Amount Raised: $34M.
• Total Raised: $49M.
• Funding Stage: Series B.
• Funding Date: May 14, 2026.

Nectar Social Raises $30M Series A for Agentic Marketing Operations

Nectar Social is building what it calls an agentic operating system for modern marketing, collapsing social intelligence, community engagement, influencer tooling, customer experience, and social analytics into a single AI-driven stack. The company emerged from stealth with two former Meta leaders at the helm and launched its autonomous Nectar Agent alongside the round.

Why this round matters: the bigger shift is not in social listening but in execution. Nectar says it is already running more than 10 million autonomous conversations per week, has attributed $100 million in revenue across those interactions, and has engaged 50 million users for brands including e.l.f. Beauty and Liquid Death. That makes this feel less like experimental martech and more like a serious attempt to turn brand operations into an AI-run workflow layer.

Funding Details

• Startup: Nectar Social.
• Investors: Menlo Ventures and Menlo’s Anthology Fund; True Ventures, GV, and Kinship Ventures.
• Amount Raised: $30M.
• Total Raised: Not disclosed.
• Funding Stage: Series A.
• Funding Date: May 14, 2026.

Iceotope Raises $26M Series B for AI Data Center Cooling

Iceotope builds precision liquid cooling systems for data centers and edge infrastructure. The Series B will go into product and engineering development, patent expansion, and partner ecosystem work designed to get more Iceotope-based systems into the market.

Why this round matters: Cooling is quickly becoming one of the hardest physical bottlenecks in AI infrastructure. Iceotope says next-generation GPU and accelerator platforms are driving rack densities toward 1MW and beyond, a level where traditional air cooling and even some direct-to-chip approaches start to break down. This is a direct bet on the idea that thermal management is now strategic infrastructure rather than datacenter plumbing.

Funding Details

• Startup: Iceotope Group.
• Investors: Two Seas Capital and Barclays Climate Ventures, with participation from Edinv, ABC Impact, Northern Gritstone, and British Patient Capital.
• Amount Raised: $26M.
• Total Raised: Not disclosed.
• Funding Stage: Series B.
• Funding Date: May 14, 2026.

Stitch Raises $25M Series A for Modern Financial Infrastructure

Stitch is building a cloud-native operating system for financial institutions that spans lending, cards, payments, and ledgers, with the goal of enabling banks to modernize module by module rather than replacing entire cores in a single painful cutover. The company says financial institutions cannot meaningfully adopt AI on top of fragmented legacy systems.

Why this round matters: This is not just another regional fintech raise. The deal marks Andreessen Horowitz’s first investment in the GCC, and Stitch says more than $5 billion moved across its platform in the last six months, with customer numbers up 10x and revenue up 20x in 2025. The strategic signal is that institutional fintech infrastructure in the Gulf is no longer niche capital; it is becoming globally contested ground.

Funding Details

• Startup: Stitch.
• Investors: Andreessen Horowitz, with participation from Arbor Ventures, COTU Ventures, Raed Ventures, and SVC.
• Amount Raised: $25M.
• Total Raised: $35M.
• Funding Stage: Series A.
• Funding Date: May 14, 2026.

GovWell Raises $25M Series A for AI-Powered Government Permitting

GovWell is taking aim at one of the most neglected workflow categories in software: local government permitting and licensing. Its platform includes an AI-powered community assistant, an application portal designed to catch errors before they slow approval, and an automated review engine that checks permit applications against local rules.

Why this round matters: permitting delays hit housing, infrastructure projects, and business formation long before they become political talking points. GovWell says more than 130 municipalities and counties across 34 states already use the platform, and that its system can reduce processing times by up to 95%. That turns this from a niche govtech story into a meaningful efficiency play in a category that still runs on decades-old software.

Funding Details

• Startup: GovWell.
• Investors: Insight Partners, with participation from Work-Bench, Bienville Capital, David Reeves, Andreas Huber, and Chris Bullock.
• Amount Raised: $25M.
• Total Raised: $34.5M.
• Funding Stage: Series A.
• Funding Date: May 14, 2026.

Wirestock Raises $23M Series A for Multimodal AI Training Data

Wirestock started as a distribution layer for photographers and creators selling through stock platforms. It has since pivoted to supplying multimodal datasets for AI labs, including images, videos, design assets, gaming content, and 3D materials.

Why this round matters: the AI stack still runs on data acquisition and curation, even if the glamour sits elsewhere. Wirestock says it now works with six of the largest foundation model makers, has brought more than 700,000 artists and designers onto its platform, and is already generating $40 million in annual revenue. That makes this one of the clearer signs that creator marketplaces are being rebuilt as AI infrastructure companies.

Funding Details

• Startup: Wirestock.
• Investors: Nava Ventures, with participation from SBVP, Formula VC, and I2BF Ventures.
• Amount Raised: $23M.
• Total Raised: About $26M.
• Funding Stage: Series A.
• Funding Date: May 14, 2026.

Optura Raises $17.5M Series A for Healthcare AI ROI Management

Optura is building an enterprise healthcare platform focused on measuring the return on AI investments, prioritizing use cases, and tracking business impact in real time. The company’s argument is that healthcare does not have an AI adoption problem; it has an AI-results problem.

Why this round matters: enterprises are drowning in AI pilots, but most still struggle to prove value. Optura says more than $2 billion in AI initiatives are already loaded into its platform, with $120 million in tracked value, more than 250 identified use cases, and reported 700% return on AI investment for in-flight programs. Investors are backing the measurement and governance layer, not just another AI application.

Funding Details

• Startup: Optura.
• Investors: Salesforce Ventures, Echo Health Ventures, Susa Ventures, Matrix Partners, and HC9 Ventures.
• Amount Raised: $17.5M.
• Total Raised: Over $25M.
• Funding Stage: Series A.
• Funding Date: May 14, 2026.

Urologic Health Raises $11M Seed for Non-Invasive Bladder Monitoring

Urologic Health is developing a catheter-free urodynamics platform that converts bladder activity into clinically useful diagnostic data. The seed round will fund clinical validation, the FDA 510(k) pathway, and its first U.S. commercialization push.

Why this round matters: bladder dysfunction affects hundreds of millions of people worldwide, but current diagnostic tools remain invasive and uncomfortable enough that many patients delay testing. If Urologic can make urodynamic assessment materially easier to use and more accessible, it could change the front end of bladder care rather than just add a better device to the same constrained workflow.

Funding Details

• Startup: Urologic Health.
• Investors: An undisclosed strategic investor, plus Edge Medical Ventures, SHD Partners, Longevity Venture Partners, and additional healthcare-focused investors.
• Amount Raised: $11M.
• Total Raised: $11M disclosed.
• Funding Stage: Seed.
• Funding Date: May 14, 2026.

Synthetic Raises $10M Seed for Autonomous Startup Bookkeeping

Synthetic is building an AI bookkeeping service for software startups that connects to banking, payroll, billing, and email systems and produces accrual-based books without human bookkeepers. The company is explicitly betting that bookkeeping can be automated end-to-end, not merely assisted.

Why this round matters: This is one of the day’s clearest “AI replaces services” bets. Khosla led the seed, Basis Set joined, and the founder, Ian Crosby, is returning to the accounting category after building Bench into a major bookkeeping startup before its collapse. That combination makes the round strategically notable well beyond its size.

Funding Details

• Startup: Synthetic.
• Investors: Khosla Ventures, Basis Set Ventures, Tobi Lütke, Kaz Nejatian, Zach Abrams, Cosmin Nicolaescu, and Michael Tannenbaum.
• Amount Raised: $10M.
• Total Raised: $10M disclosed.
• Funding Stage: Seed.
• Funding Date: May 14, 2026.

What stood out

This cycle was defined by operational AI rather than pure model labs. Nectar Social, Wirestock, Optura, GovWell, and Synthetic all sit in execution layers around AI adoption: marketing agents, data supply, ROI measurement, local-government workflows, and back-office automation. Iceotope adds the physical layer beneath that stack, underscoring that the AI buildout is now constrained as much by cooling and deployment economics as by model quality.

Fintech was also unusually infrastructure-heavy. equipifi is pushing installment lending back into bank-owned channels, while Stitch is rebuilding core financial systems for institutions that want to modernize without catastrophic migration projects. These are not consumer-app bets; they are platform bets on the wiring beneath payments, lending, and AI-ready financial operations.

Healthcare still captured the biggest single check in the set. CREATE’s $122 million Series B dominated the day numerically, and Urologic Health’s seed showed that capital is still flowing into devices and diagnostics that can remove friction from legacy care pathways. The healthcare theme here was not wellness or AI wrappers; it was clinically consequential infrastructure.

Tech Funding Summary Table